NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $729,000 | -12.4% | 66,500 | 0.0% | 0.02% | 0.0% |
| Q2 2015 | $832,000 | +24.0% | 66,500 | +9.0% | 0.02% | +25.0% |
| Q1 2015 | $671,000 | -27.4% | 61,000 | +2.3% | 0.01% | -25.0% |
| Q4 2014 | $924,000 | +28.5% | 59,600 | 0.0% | 0.02% | +23.1% |
| Q3 2014 | $719,000 | -5.9% | 59,600 | 0.0% | 0.01% | -7.1% |
| Q2 2014 | $764,000 | +5.8% | 59,600 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $722,000 | – | 59,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |